|
BAY598,SMYD2抑制剂
|
B288058-5mg
|
Moligand™, ≥98%(HPLC) |
1906919-67-2 |
5mg
|
¥ 588.9
|
现货 |
|
0 |
阿拉丁 |
|
BAY598,SMYD2抑制剂
|
B288058-25mg
|
Moligand™, ≥98%(HPLC) |
1906919-67-2 |
25mg
|
¥ 1501.9
|
现货 |
|
0 |
阿拉丁 |
|
B 973B,α7nAChRs的正变构调节剂
|
B288003-50mg
|
≥98%(HPLC) |
2244989-34-0 |
50mg
|
¥ 10199.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
B 973B,α7nAChRs的正变构调节剂
|
B288003-10mg
|
≥98%(HPLC) |
2244989-34-0 |
10mg
|
¥ 2449.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Bay 55-9837 TFA,VPAC2激动剂
|
B288002-1mg
|
Moligand™, ≥98% |
463930-25-8 |
1mg
|
¥ 2699.9
|
现货 |
|
0 |
阿拉丁 |
|
BI 01383298,SLC13A5(Na + /柠檬酸盐共转运蛋白)抑制剂
|
B287971-5mg
|
Moligand™, ≥98%(HPLC) |
2227549-00-8 |
5mg
|
¥ 637.9
|
现货 |
|
0 |
阿拉丁 |
|
BI 01383298,SLC13A5(Na + /柠檬酸盐共转运蛋白)抑制剂
|
B287971-25mg
|
Moligand™, ≥98%(HPLC) |
2227549-00-8 |
25mg
|
¥ 2483.9
|
现货 |
|
0 |
阿拉丁 |
|
BAY293,KRas / SOS1相互作用抑制剂
|
B287954-5mg
|
Moligand™, ≥98%(HPLC) |
2244904-70-7 |
5mg
|
¥ 1296.9
|
现货 |
|
0 |
阿拉丁 |
|
BS 181 2HCl,cdk7抑制剂
|
B287918-50mg
|
≥99%(HPLC) |
1883548-83-1 |
50mg
|
¥ 8354.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
BS 181 2HCl,cdk7抑制剂
|
B287918-10mg
|
≥99%(HPLC) |
1883548-83-1 |
10mg
|
¥ 1988.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
苯扎咪 盐酸盐
|
B287915-50mg
|
≥98%(HPLC) |
161804-20-2 |
50mg
|
¥ 2253.9
|
现货 |
|
0 |
阿拉丁 |
|
苯扎咪 盐酸盐
|
B287915-10mg
|
≥98%(HPLC) |
161804-20-2 |
10mg
|
¥ 499.9
|
现货 |
|
0 |
阿拉丁 |
|
BMS 470539 二盐酸盐
|
B287909-10mg
|
≥98%(HPLC) |
2341796-82-3 |
10mg
|
¥ 2799.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
BIBX 1382 二盐酸盐
|
B287903-1mg
|
≥97%(HPLC) |
1216920-18-1 |
1mg
|
¥ 1206.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
BIBX 1382 二盐酸盐
|
B287903-10mg
|
≥97%(HPLC) |
1216920-18-1 |
10mg
|
¥ 2586.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Bz 423,ATP合酶抑制剂
|
B287874-50mg
|
Moligand™, ≥98%(HPLC) |
216691-95-1 |
50mg
|
¥ 4799.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Bz 423,ATP合酶抑制剂
|
B287874-10mg
|
Moligand™, ≥98%(HPLC) |
216691-95-1 |
10mg
|
¥ 1279.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
BPTU,P2Y1别构拮抗剂
|
B287832-50mg
|
Moligand™, ≥98%(HPLC) |
870544-59-5 |
50mg
|
¥ 502.9
|
现货 |
|
0 |
阿拉丁 |
|
BPTU,P2Y1别构拮抗剂
|
B287832-10mg
|
Moligand™, ≥98%(HPLC) |
870544-59-5 |
10mg
|
¥ 281.9
|
现货 |
|
0 |
阿拉丁 |
|
BI 6015,肝细胞核因子4α(HNF4α)拮抗剂
|
B287789-50mg
|
Moligand™, ≥98%(HPLC) |
93987-29-2 |
50mg
|
¥ 689.9
|
现货 |
|
0 |
阿拉丁 |
|
BI 6015,肝细胞核因子4α(HNF4α)拮抗剂
|
B287789-10mg
|
Moligand™, ≥98%(HPLC) |
93987-29-2 |
10mg
|
¥ 250.9
|
现货 |
|
0 |
阿拉丁 |
|
BAY 87-2243,线粒体复合物I抑制剂
|
B287776-5mg
|
≥98%(HPLC) |
1227158-85-1 |
5mg
|
¥ 601.9
|
现货 |
|
0 |
阿拉丁 |
|
BAY 87-2243,线粒体复合物I抑制剂
|
B287776-25mg
|
≥98%(HPLC) |
1227158-85-1 |
25mg
|
¥ 2574.9
|
现货 |
|
0 |
阿拉丁 |
|
BMS 453,合成类维生素A和RARβ激动剂
|
B287683-10mg
|
≥98%(HPLC) |
166977-43-1 |
10mg
|
¥ 1699.9
|
现货 |
|
0 |
阿拉丁 |